What is the current Canine Vaccine market size?

The Canine Vaccine market size is approximately USD 1.2 billion as of 2023.

What is the future outlook for the Canine Vaccine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Canine Vaccine market?

Increasing pet ownership and advances in vaccine technology drive the market.

What are the major challenges facing the Canine Vaccine market?

High development costs and strict regulatory frameworks pose challenges.

Which regions lead the Canine Vaccine market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Canine Vaccine market?

Key players include Zoetis, Merck, and Boehringer Ingelheim.

What future opportunities exist in the Canine Vaccine market?

Emerging markets and innovative vaccine technologies offer growth opportunities.

How does technology impact the Canine Vaccine market?

Advances in vaccine technology improve efficacy and drive market growth.

What is the regulatory landscape for the Canine Vaccine market?

Stringent regulations ensure vaccine safety and efficacy.

How will the Canine Vaccine market evolve in the next 5 years?

The market will experience steady growth driven by increasing demand.

Canine Vaccine Market Growth Drivers & Forecast 2033

Canine Vaccine by Application (Puppies, Adult Dogs), by Types (Core Vaccines, Non-Core Vaccines), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $1742 million

CAGR: 5.9%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 120

Forecast Period: 2026 - 2033

Market Size: $1742 million

CAGR: 5.9%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Canine Vaccine Market Overview

The Canine Vaccine market is a crucial segment of the animal healthcare industry, focused on preventing and controlling diseases in dogs. As the global pet care industry expands, the Canine Vaccine market size is expected to witness significant growth, driven by increasing pet ownership, rising awareness about animal health, and advancements in vaccine technology. The growth outlook for the Canine Vaccine market is promising, with a projected market size of approximately $2.5 billion by 2026, and a forecasted Compound Annual Growth Rate (CAGR) of around 7%. The market forecast suggests that the industry will experience steady expansion during the forecast period, driven by industry expansion and increasing demand for effective canine vaccines. Key forces shaping the industry include technology shifts, such as the development of novel vaccine platforms, regulations, like stricter animal health standards, and consumer behavior, including growing pet humanization.

Loading chart…

The largest region in the Canine Vaccine market is North America, accounting for a significant share of the global market, while the fastest-growing region is Asia-Pacific, driven by increasing pet ownership and growing demand for animal healthcare services. The market is expected to be shaped by factors such as competitive intensity, supply-chain dynamics, and regulatory frameworks, which will influence the growth and development of the industry. As the Canine Vaccine market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends, challenges, and opportunities to make strategic decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	1.74 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Merck Animal Health; Pfizer; Boehringer Ingelheim; Virbac; Durvet; Elanco; RuiPu Bio-Technology; CAHIC; Wuhan Keqian Biology; Jilin Five-Star Animal Health; NeoTech; JINHE; SINOVAC; Biogenesis Bago
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Canine Vaccine market is poised for significant growth, driven by increasing pet ownership and advancements in vaccine technology. The market dynamics are shaped by various factors, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Rising demand for core and non-core Canine Vaccines due to growing awareness about zoonotic diseases and the importance of preventive care, driving the Canine Vaccine market size and growth forecast

Advances in vaccine development, such as the use of recombinant DNA technology and novel adjuvants, enhancing the efficacy and safety of canine vaccines, and contributing to the expansion of the Canine Vaccine market

Restraints2 items

High development costs and stringent regulatory requirements for new vaccine approvals, potentially limiting the entry of new players and slowing the growth forecast of the Canine Vaccine market

Vaccine hesitancy and concerns about adverse reactions, which may impact the adoption of canine vaccines and hinder the growth of the Canine Vaccine market size

Opportunities2 items

Increasing demand for personalized and precision medicine approaches in veterinary care, creating opportunities for the development of customized canine vaccines and driving innovation in the Canine Vaccine market

Growing pet humanization trend and rising spending on pet health, presenting opportunities for manufacturers to develop premium and value-added canine vaccines, and expanding the Canine Vaccine market size

Challenges2 items

Supply chain disruptions and raw material shortages, which may impact the production and availability of canine vaccines, affecting the growth forecast and Canine Vaccine market size

Intensifying competition and pricing pressure, requiring manufacturers to invest in research and development, marketing, and distribution strategies to maintain their market share in the Canine Vaccine market

Market Segmentation

Loading chart…

The Application segment of the Canine Vaccine market refers to the different uses of canine vaccines, including core vaccines and non-core vaccines. Core vaccines are essential for all dogs, providing protection against severe diseases such as rabies, distemper, and parvovirus. Non-core vaccines, on the other hand, are recommended based on a dog's lifestyle, age, and health status, and may include vaccines against diseases such as Lyme disease and leptospirosis. Understanding the Canine Vaccine segmentation by application is crucial for manufacturers to develop targeted vaccine products and for veterinarians to recommend the most suitable vaccines for their patients.

The Types segment of the Canine Vaccine market is further divided into subtypes, including inactivated vaccines, live attenuated vaccines, and recombinant vaccines. Inactivated vaccines contain killed pathogens, while live attenuated vaccines contain weakened pathogens. Recombinant vaccines, on the other hand, use genetic engineering to produce specific antigens. Each subtype has its own advantages and disadvantages, and manufacturers must carefully consider these factors when developing new vaccine products. By analyzing the market taxonomy of the Canine Vaccine market, including the types of vaccines available, industry stakeholders can better understand the complex dynamics of the market and make informed decisions.

Canine Vaccine Segmentation Breakdown6 items

Application

Puppies

Adult Dogs

Types

Core Vaccines

Non-Core Vaccines

Regional Insights

Loading chart…

The Canine Vaccine market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of canine vaccines, government initiatives, and investments in the animal healthcare sector.

Key drivers for each region include: for North America, increased pet ownership and advancements in vaccine technology; for Europe, stringent pet vaccination policies and rising awareness about zoonotic diseases; for Asia Pacific, growing demand for veterinary care and expanding distribution networks; for Latin America, government initiatives to control zoonotic diseases and _improving infrastructure; and for Middle East & Africa, _increasing investments in animal healthcare and _rising demand for veterinary services.

The regional forecast indicates that the Canine Vaccine market will experience significant growth in the coming years, driven by factors such as demographics, ecosystem maturity, and policies. As the global market continues to evolve, it is essential to monitor regional trends and developments to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Canine Vaccine market is moderately consolidated, with a mix of global players and local/regional companies driving competition. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Canine Vaccine competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios and strategic partnerships. Global players such as Zoetis and Merck Animal Health have a strong presence, while local companies focus on regional expansion and customization.

Common strategies among key players include M&A, partnerships, product launches, expansion, R&D, and localization. Companies differentiate themselves through technology, service models, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on innovation, premium pricing, and strategic partnerships.

Zoetis: regional expansion

Merck Animal Health: innovation pipeline

Pfizer: premium pricing

Boehringer Ingelheim: local manufacturing

Virbac: OEM tie-ups

Durvet: vertical integration

Key Canine Vaccine Companies15 items

Zoetis

Merck Animal Health

Pfizer

Boehringer Ingelheim

Virbac

Durvet

Elanco

RuiPu Bio-Technology

CAHIC

Wuhan Keqian Biology

Jilin Five-Star Animal Health

NeoTech

JINHE

SINOVAC

Biogenesis Bago

Market Ecosystem

The Canine Vaccine ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of canine vaccines, with various participants contributing to the overall value chain analysis.

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing canine vaccines

Distributors / channel partners — delivering vaccines to clinics

Veterinarians / veterinary clinics — administering vaccines to dogs

Regulators/standards bodies — overseeing vaccine safety and efficacy

Service providers / after-sales — offering support and guidance

End users / buyers — dog owners and breeders purchasing vaccines

The flow of value within the Canine Vaccine ecosystem is influenced by control points, such as regulatory approvals and veterinarian recommendations, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements may vary by region, leading to differences in the ecosystem's structure and dynamics across diverse areas.

Recent Industry Insights

The Canine Vaccine industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships, such as the collaboration between Zoetis and the University of Wisconsin-Madison, have accelerated innovation in the field. Furthermore, mergers and acquisitions, like the acquisition of Aratana Therapeutics by Elanco, have led to market consolidation and expansion of product portfolios.

Recent product launches, including the introduction of novel vaccine formulations and diagnostic tools, have enhanced the industry's capabilities. Regulatory changes, such as updated guidelines for vaccine efficacy and safety, have also shaped the market landscape. Additionally, a shift in consumer trends towards pet humanization and increased awareness about animal health has driven demand for canine vaccines, with companies responding through funding rounds and expansions to meet this growing need.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Canine Vaccine market outlook. The market attractiveness is moderate, driven by increasing pet ownership and a rising awareness of canine health. The competitive intensity is high, with several major players competing for market share. The long-term outlook is positive, with a growing demand for vaccines and a steady pace of innovation in the _innovation landscape_.

The demand-supply balance is expected to be stable, with key players investing in manufacturing capacity to meet growing demand. However, key risk factors such as regulatory changes and disease outbreaks may impact the market. Overall, the Canine Vaccine market is expected to experience steady growth, driven by increasing demand and innovation in the industry.

12 items

1. Executive Summary

2. Canine Vaccine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Canine Vaccine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Canine Vaccine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Canine Vaccine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Canine Vaccine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Canine Vaccine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Canine Vaccine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Canine Vaccine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Canine Vaccine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Canine Vaccine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Canine Vaccine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Canine Vaccine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Canine Vaccine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Canine Vaccine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Canine Vaccine Market Competition by Key Manufacturers

9.1. Global Canine Vaccine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Canine Vaccine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Zoetis

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Merck Animal Health

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Pfizer

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Boehringer Ingelheim

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Virbac

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Durvet

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Elanco

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. RuiPu Bio-Technology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. CAHIC

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Wuhan Keqian Biology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Jilin Five-Star Animal Health

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. NeoTech

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. JINHE

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. SINOVAC

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Biogenesis Bago

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Canine Vaccine Market

Figure 4: Global Canine Vaccine Market: Drivers

Figure 5: Global Canine Vaccine Market: Challenges

Figure 6: Global Canine Vaccine Market: Trends

Figure 7: Global Canine Vaccine Market: Opportunity

Figure 8: Global Canine Vaccine Market: Restraint

Figure 9: Global Canine Vaccine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Canine Vaccine Market Value (USD Million) By Region

Figure 19: Global Canine Vaccine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Canine Vaccine Market Value (USD Million) By Region

Figure 27: Global Canine Vaccine Market Share (%) By: Regions (2032)

Figure 28: Global Canine Vaccine Market Volume (K) By Region

Figure 29: Global Canine Vaccine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Canine Vaccine Market Value (USD Million) By Region

Figure 37: Global Canine Vaccine Market Share (%) By: Regions (2032)

Figure 38: Global Canine Vaccine Market Volume (K) By Region

Figure 39: Global Canine Vaccine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Canine Vaccine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Canine Vaccine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Canine Vaccine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Canine Vaccine Market Value (USD Million) By Region

Table 14: Global Canine Vaccine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Canine Vaccine Market Volume (K) By Region

Table 31: Global Canine Vaccine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Canine Vaccine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Canine Vaccine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Canine Vaccine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Zoetis Basic Information And Sales Area

Table 52: Zoetis. Products Portfolio

Table 53: Merck Animal Health Basic Information And Sales Area

Table 54: Merck Animal Health. Products Portfolio

Table 55: Pfizer Basic Information And Sales Area

Table 56: Pfizer. Products Portfolio

Table 57: Boehringer Ingelheim Basic Information And Sales Area

Table 58: Boehringer Ingelheim. Products Portfolio

Table 59: Virbac Basic Information And Sales Area

Table 60: Virbac. Products Portfolio

Table 61: Durvet Basic Information And Sales Area

Table 62: Durvet. Products Portfolio

Table 63: Elanco Basic Information And Sales Area

Table 64: Elanco. Products Portfolio

Table 65: RuiPu Bio-Technology Basic Information And Sales Area

Table 66: RuiPu Bio-Technology. Products Portfolio

Table 67: CAHIC Basic Information And Sales Area

Table 68: CAHIC. Products Portfolio

Table 69: Wuhan Keqian Biology Basic Information And Sales Area

Table 70: Wuhan Keqian Biology. Products Portfolio

Table 71: Jilin Five-Star Animal Health Basic Information And Sales Area

Table 72: Jilin Five-Star Animal Health. Products Portfolio

Table 73: NeoTech Basic Information And Sales Area

Table 74: NeoTech. Products Portfolio

Table 75: JINHE Basic Information And Sales Area

Table 76: JINHE. Products Portfolio

Table 77: SINOVAC Basic Information And Sales Area

Table 78: SINOVAC. Products Portfolio

Table 79: Biogenesis Bago Basic Information And Sales Area

Table 80: Biogenesis Bago. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Canine Vaccine Market Value (USD Million) By Region

Table 90: Global Canine Vaccine Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Canine Vaccine Market Volume (K) By Region

Table 107: Global Canine Vaccine Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Canine Vaccine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.74 billion
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Zoetis; Merck Animal Health; Pfizer; Boehringer Ingelheim; Virbac; Durvet; Elanco; RuiPu Bio-Technology; CAHIC; Wuhan Keqian Biology; Jilin Five-Star Animal Health; NeoTech; JINHE; SINOVAC; Biogenesis Bago
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Vaccine hesitancy and concerns about adverse reactions, which may impact the adoption of canine vaccines and hinder the growth of the Canine Vaccine market size

Opportunities2 items

Challenges2 items

Supply chain disruptions and raw material shortages, which may impact the production and availability of canine vaccines, affecting the growth forecast and Canine Vaccine market size

Market Segmentation

Loading chart…

Canine Vaccine Segmentation Breakdown6 items

Application

Puppies

Adult Dogs

Types

Core Vaccines

Non-Core Vaccines

Regional Insights

Loading chart…

Competitive Landscape

Zoetis: regional expansion

Merck Animal Health: innovation pipeline

Pfizer: premium pricing

Boehringer Ingelheim: local manufacturing

Virbac: OEM tie-ups

Durvet: vertical integration

Key Canine Vaccine Companies15 items

Zoetis

Merck Animal Health

Pfizer

Boehringer Ingelheim

Virbac

Durvet

Elanco

RuiPu Bio-Technology

CAHIC

Wuhan Keqian Biology

Jilin Five-Star Animal Health

NeoTech

JINHE

SINOVAC

Biogenesis Bago

Market Ecosystem

Raw material suppliers — providing vaccine components

OEMs / manufacturers — producing canine vaccines

Distributors / channel partners — delivering vaccines to clinics

Veterinarians / veterinary clinics — administering vaccines to dogs

Regulators/standards bodies — overseeing vaccine safety and efficacy

Service providers / after-sales — offering support and guidance

End users / buyers — dog owners and breeders purchasing vaccines

Recent Industry Insights

Analyst Overview

Table of Contents